Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients

Clinical trial NCT03873987 · COMPLETED

Trial details

NCT number: NCT03873987
Sponsor: Melinta Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Bacterial Skin and Skin Structure Infection

Start date: 2019-07-16
Primary completion: 2019-08-27
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.